⌘K

Login Start Free

Home/Filings/4/0001214659-21-003154

4//SEC Filing

Krop Julie 4

Accession 0001214659-21-003154

CIK 0001398733other

View on SEC.gov Company Profile

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 5:10 PM ET

Size

5.4 KB

Accession

0001214659-21-003154

Insider Transaction Report

Form 4

Period: 2021-03-11

Aquestive Therapeutics, Inc.AQST

Director

Transactions

Award
Non-Qualified Stock Option (right to buy)
2021-03-11+28,500→ 28,500 total
Exercise: $5.30Exp: 2031-03-11→ Common Stock (28,500 underlying)

Footnotes (1)

[F1]The option vests in three equal annual installments beginning on March 11, 2022.

Documents

1 file

4
marketforms-51884.xmlPrimary
PRIMARY DOCUMENT

Issuer

Aquestive Therapeutics, Inc.

CIK 0001398733

Entity typeother

Related Parties

1

filerCIK 0001643127

Filing Metadata

Form type: 4
Filed: Mar 14, 8:00 PM ET
Accepted: Mar 15, 5:10 PM ET
Size: 5.4 KB

View on SEC.gov